NATERA, INC.

Public Equity (NASDAQ)PublicDiagnosticsBiotech

📍 Austin, TX, United States• Founded 2004

StreetZero Signal 59

Be the first to signal interest

About NATERA, INC.

Natera, Inc. is a diagnostics company focused on cell-free DNA testing for applications in prenatal care, oncology, and organ health. It provides non-invasive prenatal testing and genomic assays and is publicly traded on NASDAQ under ticker NTRA. The company operates from a base in Austin, Texas.

LATEST FUNDINGRule 144

$312K

Announced 2026-10-27

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for NATERA, INC..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES—

FOUNDED2004

HQAustin, TX, United States

Industry

Public Equity (NASDAQ)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Completed $312,177.9 Rule 144 transaction
Publicly traded on NASDAQ as NTRA
Headquartered in Austin, TX

Ask StreetZero about NATERA, INC.

Put our AI to work on this deal.

What is NATERA, INC.'s value proposition?Who are NATERA, INC.'s competitors?Why does this raise matter?Summarize NATERA, INC. for an investor.

Similar companies

Other Public Equity (NASDAQ) deals, ranked by Signal.

Paylocity Holding Corporation

$66.0M

BENTLEY SYSTEMS INC

$67.5M

Crowdstrike Holdings, Inc.

$141.0M

Palo Alto Networks Inc

$201.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.